https://www.selleckchem.com/products/sr-4835.html
There was no statistical difference in the primary or secondary outcomes between the quartiles except acute kidney injury was less frequent in quartile 4. There is no significant association between HbA level and adverse clinical outcomes in patients with diabetes who are hospitalized with COVID-19. HbA should not be used for risk stratification in these patients. There is no significant association between HbA1c level and adverse clinical outcomes in patients with diabetes who are hospitalized with COVID-19. HbA1c should not be used fo
Like
Comment
Share
